Fresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2016
Fresenius Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"), the world's largest provider of dialysis products and services, announced that it has filed the annual report 2016 under form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is available at the company's website www.freseniusmedicalcare.com in the "Investors" section as well as at the SEC's website, www.sec.gov .
A hard copy of Fresenius Medical Care's annual report on form 20-F including the complete audited financial statements may be obtained from the company free of charge upon request to the company's Investor Relations department by email at email@example.com .
Fresenius Medical Care is the world's largest provider of products and services for individuals with renal diseases of which around 3 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,624 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 308,471 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit the Company's website at www.freseniusmedicalcare.com .
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
|Company:||Fresenius Medical Care AG & Co. KGaA|
|61352 Bad Homburg|
|Phone:||+49 (0) 6172- 609 2525|
|Fax:||+49 (0) 6172- 609 2301|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE|
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FL-GE-AVIATION16.10.2018 00:19 | pressemeddelelse
GE’s AffinityTM: The first civil supersonic engine in 55 years – launching a new era of efficient supersonic flight
NY-IFF15.10.2018 22:17 | pressemeddelelse
IFF to Release Third Quarter 2018 Results November 5
SUMITOMO-SHI-FW15.10.2018 22:02 | pressemeddelelse
Sumitomo SHI FW Wins Contract for Biomass CFB Boiler Island in South Korea
AMPLEXOR15.10.2018 21:11 | pressemeddelelse
AMPLEXOR to Present on Neural Machine Translation Engine at Artificial Intelligence Event: 30 Years of DFKI – 30 Years of AI for Humans
KRAMER-LEVIN-NAFTALIS15.10.2018 18:56 | pressemeddelelse
Lehman Brothers Treasury to Further Explore Strategic Opportunities
SFL15.10.2018 18:30 | pressemeddelelse
SFL – Third-Quarter 2018 Financial Information
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum